{"ticker": {"uuid": "730a76ac-cafa-4651-88e5-dfd38c144c11", "symbol": "PROK", "name": "ProKidney Corp.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "ProKidney Corp. (PROK) Q1 2026 Earnings: In-Line EPS, Pre-Revenue Progress Drives Modest Stock Gain - Consensus Miss Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPX0E5eEYtdFZQWEVEMzJ2WUxGdExaSE5jZVRidF9YOHRSSkZpdklqTG5mS0g2c2VxX3hkdG42N20ydWtOMFJiUEh5NmJRY3A3Z0FiU1Y4emswVGxhUzFOTVJodEtvZ1k1MDBWZjJ4b1l1c0dKMXFYVmpLMW02R3AwRjlpdzFsZUNMSXFXRUgzUkVkTzA1M3pZOEM5cW5QdnZ1anBBZ01tdjhGYjZvUUJSZXRZVkNzaEhqVkJrUHM1T09wNDdpWHY2NlpyLWFkcDdGbnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-19T10:31:20+00:00", "published_display": "19 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp (PROK) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFAyWUFEUWhLd09SX2tqemh3U2pSdXFYbjZMQ2JUZXplRExtVFNEZkxDU1VTUWdnMWFKT01seXBkdGpYVDljSEs0el9MWW1KY3pmQ3c5VjRNeUZaR1FqTXRrWVpYc0VyYXZZU1JucFA3U0s?oc=5", "source_name": "TradingKey", "published_at": "2026-07-17T07:00:00+00:00", "published_display": "17 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. Q1 2026 Earnings: Clinical-Stage Biotech Posts Narrower-Than-Expected Loss, Shares Rally - EPS Revision Trend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNcVN6MkJndHlWMFRqTnh1VHBJTWNIRGJ1VnNVTV9MNG4zclNvYk9vRkNsV1VLRU0xOVB2dXNld2dqZHNfLXNreUNPODNPLXA5T3V3VHI5RTI0OEhKNUtyNmNNTUNKRzdrQU92NTd3TmxCWktlblZyenV3anNiMEJ2S1ZBemdnd2tlWE9FR21HbXpOV1dSRnFUdzVPYnJiVzkzMTFTZjVqME5lZWUxNjcyeUdoekc4c0pDX1RMZVRkOW1nTlMwaUVyRWxSak40ejRGNjNwWDVfc2tPQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-16T10:34:08+00:00", "published_display": "16 Jul 2026 10:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ:PROK): Can This Penny Stock Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPOGVEcC00ZXdpNWdMSVEzWkVyR3hTd1dMRjBNaFltTm5yVE1NVGpDMERGcnhDT1JWMldCMTRFS1JaRkJ4OFBVQlVtbGVfME5sXzVtRFhmVWRGRzJ1bXpRN1o3b0tzOFZtSnUtSmxGT3RWVzNNc182cnlScjd0ZDA4TmtGZENfLVphc0hkS2ZyaG82Z0JP?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-09T20:23:00+00:00", "published_display": "09 Jul 2026 20:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ: PROK) CTO awarded 750,000 stock options at $1.89 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQZXctRmZqUGxTRWJDU3hFUmpjaXZFdlpPNEdFaWktelM5a1pmQ3FwMWdsLUVZb2x1bjdzeWZRVVF3aGtwWWNiMjViRnZmcjE0UWdMWlZDaGl4cjZNczQ4RFQtSDJmM1FBbjFQbEY0ejh0ZTcycmZwSUxvZmpUNGwwNWFrR2IzbGYtci00NERoWnZvdHk5MUlYNHZqUzhTeG9wdmlNSEFfWGJVTG44?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Factor Crowding", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdldDUHpoX2lxMUEzZmZVVHhBSV9ZZEtQSngzZ1RVcTY3NUlGRVRWNWktdzgybW90VnlISl9XUnY5b1psc2UyZGZDUGZzNmt1aTlVWmJQSnIzOEo2ZXcxaU1TVzJodE9SWF9OY3JHU2YzTmJDelVhMWlmN0xrendLRDE4bFFTYWY2cXJoRmxJa18tU0lzLW5HaFY2OGVEWC1PSFFMSE9YTnZTS2d2dXBQVUF1cGNQUi1aSkF6Sw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T17:40:43+00:00", "published_display": "03 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Sentiment Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPd3JMdy1XVEZUcXdWeE1TLUdvOER4UXZ3cVFxeVRSbEt1U3lQeE50UnBlTC00R2N5bUhodE44OHdtS0lydkEyaVNyY05mdW01Rk1DMUJpTHlNcVRCeWZRaFphTG5jM0tPTXVXUWR1UFpJZjBZa0ZPaHB1WVU5VXlITGxWU2tzUmJiUWtRZUhkMFRhTmIzeGxQMHNoYVF6WWw1d1FPU3I5UGdfTWhNc0htME4xdWJpNmFKWkE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp (PROK) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE83Nl9KdDd2ek9JS2ExcW9NZ0ZvWUVFS2FPcjE3cnRnUEdWX1Q5NndienY2R0ZISjFXcFF2SW4tNDZpOFdaSVhsMjZnZ3B3bDdLYkNxYzhEVEVudXFmTzBvSHlzTDk4Mzg2bmdCT0VSSEpCaDd1NmV0VnlRTQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:42:23+00:00", "published_display": "19 Jun 2026 02:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel\u2019s Accelerated Approval Path", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPeVNJZzJYY2pUNF90MGZIbndWV3lTeWY2clpMV1RKWEFmczNJQW5lNDlxQ29NRDJ4QTNVX20wb0Y5dXdSODBkMjRKWHB5dzUzNlNjNUpoT0hhQ0hsaHkxTnU0bjlzVXVoNkRqY0ppOEkyVWZPRkVPdVN4YVJMMWd6RDIwUG9SUFZFSWNxSzZwSnFXUnhBODNPRg?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ: PROK) legal chief converts paired units to Class A stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQX2MtTVBGcnhJenN0MXlJNkVFVUptWmRUbnlKQUNyVUd4OHg3ZVRrVXo3Ukg1Z3pucXZaaUM0MDlpZ3JXTHJ4VGppYnlFQ1pMMXJXTVdVQ2JzMU1zRWpwZ09BQ2ZVOTJTYjlkVVFFRFlzcTJmSnprbkw1QmhTblhHQlJ5VzdlbjJqcnAzekNXTm9VU1ItS3g0ZVA2am5sMW85YjRJQnhrR3RCT3Bj?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] PROKIDNEY CORP. Initial Statement of Beneficial Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckVNY3NsX1NPeEVobWU3WlBSanZNWk9sZGVCd2d1UTZqQlVzQ1JrYXlhNVFzSXUybEZWdlFFejk5cTN6eEtpUG1vRUdLWGF6djhEc2dwRjR0ZXg3VHBOMjdTS0hON2Zhc3pvV2JSMndDOE1Va2JhWXdIMWxzeDhDNmJlRzVEbFVjVTNpaXJqa3pMZzRDRkhuRG1XNlJEUTI5Qml5VW8tcXJYYzgxYnVZeVFJY3ctQVJwWWd1LXdGRWd1eWc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Appoints Kenneth Locke as Chief Technical Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOT05NUU5idWZLd3VEc3VJUnp3N1gzNzAybUZwS01qZm53aEZPTkgyZzV6MWphb3JOcDNNbnFmYzhkaXZuQS11Mkk1QVBwbG9Bak9abVVTYlBfLWN6bTlZZUxsWjNpRXRNN0VNU2k0X3ZuYjdPM1pQRmQtRmVJTDlBNFF1TWdSejJXV2ZyVDJpdmRyQ3VmVlV3VUZuTDdBZDZETG9XcWdSLTAtMXlxNGthc2ZoMXNOQ3NRM00yN1hCRXF4dE5xWEhjM1RPbw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcW85Qml2ek9VVkhTdXpvOXBBdVp4MHcwS003aGRXRTdxNHZtTkpJNm9weDE0QkI5SjNVRG83ZHpabkM0MVk2VXlNYk0xZVZiMWV5YWpCbTVnbkpkTm9qZ3RiUnNhZ0pqX0FWY3FKWm0wNHEzM0lFQS1CdmkyZFRPdHVCaUUzNmhjWWxzQ1FVUXRxbXlRMm90VW9CQTBhZnFEd2tmQl93UW5vXzVTbXR5YU9zaEJvcFZwRUM1WTNXX0lrbGtBX0NnNFpDQXBVR2F1Z2J0RktmelR1bGNCRmhKZ0FrZV8?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOTXNkWHVLQWVzdHd6dTlHMk5PejRCbUhqZFRUbXZsRDU3QVlkaTBSMy1qbG1SRGRWSmVLdlV1WTRkVVpXb3VtZFpYenh5V3BHQlBpRGptdlYzYlVIMWxER2VmUXZwSTBXVjFVUEVkUmtxbEhaeUtlelBjVmRTWVZ3aHdJZkRzXzl0Nlg3bVVVRDh0OU92YXNfQmk2TVdmNElZ?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVm9EZ01DZlV5eDRIYlRhY0lnRUs1NzgzbTAxc3pZX0Rnel9XaGtkSUtRdmIxc0FlRlFrZ0N0ejNoVmpUeThPTXFlaHJkQWREemtYUTNZdjlDRm1SZjVUUHlvc3N1NVo5Zkc3LUt6cHk5c0pFdlZmMEpNbnlpMTEtMklTVW9icHdOQjhWQW81bC1DSi1wQlFIeDFUeXJtZ1RIYlh1b3c4dWg?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes ProKidney Corp. (PROK) So Attractive", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNDc3ZTYyVGl6MTZ5SzlBTlk1N3hJamZUdV9jcWwyQjFNQ2Z0ZlNwaGgxYURPY1M4SEw4TlRkNURmOHRxck9BV1pXSmpyYmhYdWlmUGkyT2taS1FFVXc3dGdNYlY1MTZuWlpPVkVVbldZVHZVMEVYSS1KQnFyRU93akdFdXJHQzFWZmN5eGFVNEt4VzRYc0E0RXB0dHVmUTEwM0ZhQlFWeUg?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQU0pTa1Zmckh5WGZIOC1Tc2xsTV9kM3MxNkIyUGNGRG1RRU93YVNNSGR4OU1MQVZiWUowNVp4YWpBRThkbjVYRmdFWUJGVWZpeGQtYk1DLTdqRHdSQWUtWHRuU3Uxalk2UkVPM2ZpdWdNSlRFRFRFQkJJRUJfYU93MVNkbFQ2NjFvazBCaHFrY3Q0M2hTZm1nQmNWMzNicENteHV5NTgxNGlHNGc5VlpjOFRtMjV5cHc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ProKidney Corp. (PROK) Q1 2026 Earnings: In-Line EPS, Pre-Revenue Progress Drives Modest Stock Gain - Consensus Miss Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPX0E5eEYtdFZQWEVEMzJ2WUxGdExaSE5jZVRidF9YOHRSSkZpdklqTG5mS0g2c2VxX3hkdG42N20ydWtOMFJiUEh5NmJRY3A3Z0FiU1Y4emswVGxhUzFOTVJodEtvZ1k1MDBWZjJ4b1l1c0dKMXFYVmpLMW02R3AwRjlpdzFsZUNMSXFXRUgzUkVkTzA1M3pZOEM5cW5QdnZ1anBBZ01tdjhGYjZvUUJSZXRZVkNzaEhqVkJrUHM1T09wNDdpWHY2NlpyLWFkcDdGbnc?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-19T10:31:20+00:00", "published_display": "19 Jul 2026 10:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp (PROK) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFAyWUFEUWhLd09SX2tqemh3U2pSdXFYbjZMQ2JUZXplRExtVFNEZkxDU1VTUWdnMWFKT01seXBkdGpYVDljSEs0el9MWW1KY3pmQ3c5VjRNeUZaR1FqTXRrWVpYc0VyYXZZU1JucFA3U0s?oc=5", "source_name": "TradingKey", "published_at": "2026-07-17T07:00:00+00:00", "published_display": "17 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. Q1 2026 Earnings: Clinical-Stage Biotech Posts Narrower-Than-Expected Loss, Shares Rally - EPS Revision Trend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNcVN6MkJndHlWMFRqTnh1VHBJTWNIRGJ1VnNVTV9MNG4zclNvYk9vRkNsV1VLRU0xOVB2dXNld2dqZHNfLXNreUNPODNPLXA5T3V3VHI5RTI0OEhKNUtyNmNNTUNKRzdrQU92NTd3TmxCWktlblZyenV3anNiMEJ2S1ZBemdnd2tlWE9FR21HbXpOV1dSRnFUdzVPYnJiVzkzMTFTZjVqME5lZWUxNjcyeUdoekc4c0pDX1RMZVRkOW1nTlMwaUVyRWxSak40ejRGNjNwWDVfc2tPQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-16T10:34:08+00:00", "published_display": "16 Jul 2026 10:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ:PROK): Can This Penny Stock Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPOGVEcC00ZXdpNWdMSVEzWkVyR3hTd1dMRjBNaFltTm5yVE1NVGpDMERGcnhDT1JWMldCMTRFS1JaRkJ4OFBVQlVtbGVfME5sXzVtRFhmVWRGRzJ1bXpRN1o3b0tzOFZtSnUtSmxGT3RWVzNNc182cnlScjd0ZDA4TmtGZENfLVphc0hkS2ZyaG82Z0JP?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-09T20:23:00+00:00", "published_display": "09 Jul 2026 20:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ: PROK) CTO awarded 750,000 stock options at $1.89 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQZXctRmZqUGxTRWJDU3hFUmpjaXZFdlpPNEdFaWktelM5a1pmQ3FwMWdsLUVZb2x1bjdzeWZRVVF3aGtwWWNiMjViRnZmcjE0UWdMWlZDaGl4cjZNczQ4RFQtSDJmM1FBbjFQbEY0ejh0ZTcycmZwSUxvZmpUNGwwNWFrR2IzbGYtci00NERoWnZvdHk5MUlYNHZqUzhTeG9wdmlNSEFfWGJVTG44?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Factor Crowding", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdldDUHpoX2lxMUEzZmZVVHhBSV9ZZEtQSngzZ1RVcTY3NUlGRVRWNWktdzgybW90VnlISl9XUnY5b1psc2UyZGZDUGZzNmt1aTlVWmJQSnIzOEo2ZXcxaU1TVzJodE9SWF9OY3JHU2YzTmJDelVhMWlmN0xrendLRDE4bFFTYWY2cXJoRmxJa18tU0lzLW5HaFY2OGVEWC1PSFFMSE9YTnZTS2d2dXBQVUF1cGNQUi1aSkF6Sw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T17:40:43+00:00", "published_display": "03 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Sentiment Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPd3JMdy1XVEZUcXdWeE1TLUdvOER4UXZ3cVFxeVRSbEt1U3lQeE50UnBlTC00R2N5bUhodE44OHdtS0lydkEyaVNyY05mdW01Rk1DMUJpTHlNcVRCeWZRaFphTG5jM0tPTXVXUWR1UFpJZjBZa0ZPaHB1WVU5VXlITGxWU2tzUmJiUWtRZUhkMFRhTmIzeGxQMHNoYVF6WWw1d1FPU3I5UGdfTWhNc0htME4xdWJpNmFKWkE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp (PROK) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE83Nl9KdDd2ek9JS2ExcW9NZ0ZvWUVFS2FPcjE3cnRnUEdWX1Q5NndienY2R0ZISjFXcFF2SW4tNDZpOFdaSVhsMjZnZ3B3bDdLYkNxYzhEVEVudXFmTzBvSHlzTDk4Mzg2bmdCT0VSSEpCaDd1NmV0VnlRTQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:42:23+00:00", "published_display": "19 Jun 2026 02:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel\u2019s Accelerated Approval Path", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPeVNJZzJYY2pUNF90MGZIbndWV3lTeWY2clpMV1RKWEFmczNJQW5lNDlxQ29NRDJ4QTNVX20wb0Y5dXdSODBkMjRKWHB5dzUzNlNjNUpoT0hhQ0hsaHkxTnU0bjlzVXVoNkRqY0ppOEkyVWZPRkVPdVN4YVJMMWd6RDIwUG9SUFZFSWNxSzZwSnFXUnhBODNPRg?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (NASDAQ: PROK) legal chief converts paired units to Class A stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQX2MtTVBGcnhJenN0MXlJNkVFVUptWmRUbnlKQUNyVUd4OHg3ZVRrVXo3Ukg1Z3pucXZaaUM0MDlpZ3JXTHJ4VGppYnlFQ1pMMXJXTVdVQ2JzMU1zRWpwZ09BQ2ZVOTJTYjlkVVFFRFlzcTJmSnprbkw1QmhTblhHQlJ5VzdlbjJqcnAzekNXTm9VU1ItS3g0ZVA2am5sMW85YjRJQnhrR3RCT3Bj?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] PROKIDNEY CORP. Initial Statement of Beneficial Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOckVNY3NsX1NPeEVobWU3WlBSanZNWk9sZGVCd2d1UTZqQlVzQ1JrYXlhNVFzSXUybEZWdlFFejk5cTN6eEtpUG1vRUdLWGF6djhEc2dwRjR0ZXg3VHBOMjdTS0hON2Zhc3pvV2JSMndDOE1Va2JhWXdIMWxzeDhDNmJlRzVEbFVjVTNpaXJqa3pMZzRDRkhuRG1XNlJEUTI5Qml5VW8tcXJYYzgxYnVZeVFJY3ctQVJwWWd1LXdGRWd1eWc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Appoints Kenneth Locke as Chief Technical Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOT05NUU5idWZLd3VEc3VJUnp3N1gzNzAybUZwS01qZm53aEZPTkgyZzV6MWphb3JOcDNNbnFmYzhkaXZuQS11Mkk1QVBwbG9Bak9abVVTYlBfLWN6bTlZZUxsWjNpRXRNN0VNU2k0X3ZuYjdPM1pQRmQtRmVJTDlBNFF1TWdSejJXV2ZyVDJpdmRyQ3VmVlV3VUZuTDdBZDZETG9XcWdSLTAtMXlxNGthc2ZoMXNOQ3NRM00yN1hCRXF4dE5xWEhjM1RPbw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Reports First Quarter 2026 Financial Results and Business Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcW85Qml2ek9VVkhTdXpvOXBBdVp4MHcwS003aGRXRTdxNHZtTkpJNm9weDE0QkI5SjNVRG83ZHpabkM0MVk2VXlNYk0xZVZiMWV5YWpCbTVnbkpkTm9qZ3RiUnNhZ0pqX0FWY3FKWm0wNHEzM0lFQS1CdmkyZFRPdHVCaUUzNmhjWWxzQ1FVUXRxbXlRMm90VW9CQTBhZnFEd2tmQl93UW5vXzVTbXR5YU9zaEJvcFZwRUM1WTNXX0lrbGtBX0NnNFpDQXBVR2F1Z2J0RktmelR1bGNCRmhKZ0FrZV8?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOTXNkWHVLQWVzdHd6dTlHMk5PejRCbUhqZFRUbXZsRDU3QVlkaTBSMy1qbG1SRGRWSmVLdlV1WTRkVVpXb3VtZFpYenh5V3BHQlBpRGptdlYzYlVIMWxER2VmUXZwSTBXVjFVUEVkUmtxbEhaeUtlelBjVmRTWVZ3aHdJZkRzXzl0Nlg3bVVVRDh0OU92YXNfQmk2TVdmNElZ?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVm9EZ01DZlV5eDRIYlRhY0lnRUs1NzgzbTAxc3pZX0Rnel9XaGtkSUtRdmIxc0FlRlFrZ0N0ejNoVmpUeThPTXFlaHJkQWREemtYUTNZdjlDRm1SZjVUUHlvc3N1NVo5Zkc3LUt6cHk5c0pFdlZmMEpNbnlpMTEtMklTVW9icHdOQjhWQW81bC1DSi1wQlFIeDFUeXJtZ1RIYlh1b3c4dWg?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes ProKidney Corp. (PROK) So Attractive", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNDc3ZTYyVGl6MTZ5SzlBTlk1N3hJamZUdV9jcWwyQjFNQ2Z0ZlNwaGgxYURPY1M4SEw4TlRkNURmOHRxck9BV1pXSmpyYmhYdWlmUGkyT2taS1FFVXc3dGdNYlY1MTZuWlpPVkVVbldZVHZVMEVYSS1KQnFyRU93akdFdXJHQzFWZmN5eGFVNEt4VzRYc0E0RXB0dHVmUTEwM0ZhQlFWeUg?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQU0pTa1Zmckh5WGZIOC1Tc2xsTV9kM3MxNkIyUGNGRG1RRU93YVNNSGR4OU1MQVZiWUowNVp4YWpBRThkbjVYRmdFWUJGVWZpeGQtYk1DLTdqRHdSQWUtWHRuU3Uxalk2UkVPM2ZpdWdNSlRFRFRFQkJJRUJfYU93MVNkbFQ2NjFvazBCaHFrY3Q0M2hTZm1nQmNWMzNicENteHV5NTgxNGlHNGc5VlpjOFRtMjV5cHc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 17, "sentiment_summary": {"positive": 0, "negative": 2, "neutral": 15, "score": 48, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 6.95, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 27.59, "latest_week": "2026-07-17", "one_week_move": -13.8, "four_week_move": -9.8, "twelve_week_move": -21.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.381766, "market_dynamics_buy_signal": false, "relative_strength": -34.545929, "fair_value_gap": -37.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 25.6947, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-13.8% over one week, -9.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "dars.gov.et", "count": 4}, {"label": "Market source", "count": 4}, {"label": "Stock Titan", "count": 3}, {"label": "TradingKey", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "Kalkine Media", "count": 1}, {"label": "Seeking Alpha", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 4}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-13.8% over one week, -9.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ProKidney Corp. (PROK) Q1 2026 Earnings: In-Line EPS, Pre-Revenue Progress Drives Modest Stock Gain - Consensus Miss Rate"}], "updated_at": "2026-07-21T22:06:26.478402+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}